Hyderabad : Dr Reddy's Labs has announced that Jayanth Sridhar has resigned from the position of Global Head of Biologics of the Company to pursue aspirations outside the Company.

He will cease to be in employment and Senior Management Personnel of the Company, effective from the close of business hours on January 31, 2026.

Read also: Dr Reddy's Labs ropes in Srinivas Mallavarapu as Head, Global Portfolio and Head, Business Development, North America

Established in 1984, Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. The Company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology

See Full Page